Brokerages Expect Charles River Laboratories International, Inc....


Wall Street brokerages expect Charles River Laboratories International, Inc. to post sales of $459.17 million for the current quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Charles River Laboratories International's earnings, with the highest sales estimate coming in at $471.00 million and the lowest estimate coming in at $454.50 million.



from Biotech News